Evidence map›Paper›PMID 35089627›Full record

ArticleJournal of evaluation in clinical practice2022

High quality (certainty) evidence changes less often than low-quality evidence, but the magnitude of effect size does not systematically differ between studies with low versus high-quality evidence.

Benjamin Djulbegovic, Muhammad Muneeb Ahmed, Iztok Hozo, Despina Koletsi, Lars Hemkens, Amy Price, Rachel Riera, Paulo Nadanovsky, Ana Paula Pires Dos Santos, Daniela Melo and 5 more

Abstract read
In one paragraph

Article in Journal of evaluation in clinical practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Benjamin DjulbegovicDepartment of Computational & Quantitative Medicine, Beckman Research Institute, City of Hope, Duarte, California, USA.ORCID 0000-0003-0671-1447
Muhammad Muneeb AhmedMichael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0003-4208-6247
Iztok HozoDepartment of Mathematics, Indiana University Northwest, Gary, Indiana, USA.
Despina KoletsiClinic of Orthodontics and Pediatric Dentistry, Center of Dental Medicine, University of Zurich, Zurich, Switzerland.
Lars HemkensDepartment of Clinical Research, University of Basel, Basel Institute for Clinical Epidemiology & Biostatistics, University Hospital Basel, Basel, Switzerland.
Amy PriceAnesthesia Informatics and Media Lab, Stanford University, Stanford, California, USA.
Rachel RieraUniversidade Federal de São Paulo, Escola Paulista de Medicina, Brazil (Unifesp), São Paulo, Brazil.
Paulo NadanovskyDepartment of Epidemiology and Quantitative Methods in Health, National School of Public Health, Fundação Oswaldo Cruz (FIOCRUZ) - Department of Epidemiology, Institute of Social Medicine, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.
Ana Paula Pires Dos SantosDepartment of Pharmaceutical Sciences, Universidade Federal de São Paulo (Unifesp), Rio de Janeiro, Brazil.
Daniela MeloDepartment of Community and Preventive Dentistry, Faculty of Dentistry, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.
Ranjan PathakDepartment of Medical Oncology and Therapeutics Research, City of Hope, Duarte, California, USA.
Rafael Leite PachecoCentro Universitário São Camilo, Researcher at the Center of Health Technology Assessment, Hospital Sirio-Libanês, São Paulo, Brazil.
Luis Eduardo FontesCentro Universitário São Camilo, Researcher at the Center of Health Technology Assessment, Hospital Sirio-Libanês, São Paulo, Brazil.
Enderson MirandaDepartment of Intensive Care, and Emergency Medicine at Faculdade de Medicina de Petrópolis, in Petrópolis, Rio de Janeiro, Brazil.
David NunanDepartment of Intensive Care, and Emergency Medicine at Faculdade de Medicina de Petrópolis, in Petrópolis, Rio de Janeiro, Brazil.

Funding

PA-20-070 "Development of evidence-based decision support for the management of COVID19"R01HS024917 · AHRQ · UNIVERSITY OF SOUTH FLORIDA · PI DJULBEGOVIC, BENJAMIN · 2016 to 2021
$2.3M
AHRQ HHS R01 HS024917
6 · The paper itself

Abstract

RATIONALE, AIMS, AND

objectivesIt is generally believed that evidence from low quality of evidence generate inaccurate estimates about treatment effects more often than evidence from high (certainty) quality evidence (CoE). As a result, we would expect that (a) estimates of effects of health interventions initially based on high CoE change less frequently than the effects estimated by lower CoE (b) the estimates of magnitude of effect size differ between high and low CoE. Empirical assessment of these foundational principles of evidence-based medicine has been lacking.

methodsWe reviewed the Cochrane Database of Systematic Reviews from January 2016 through May 2021 for pairs of original and updated reviews for change in CoE assessments based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) method. We assessed the difference in effect sizes between the original versus updated reviews as a function of change in CoE, which we report as a ratio of odds ratio (ROR). We compared ROR generated in the studies in which CoE changed from very low/low (VL/L) to moderate/high (M/H) versus M/H to VL/L. Heterogeneity and inconsistency were assessed using the tau and I

resultsFour hundred and nineteen pairs of reviews were included of which 414 (207 × 2) informed the CoE appraisal and 384 (192 × 2) the assessment of effect size. We found that CoE originally appraised as VL/L had 2.1 [95% confidence interval (CI): 1.19-4.12; p = 0.0091] times higher odds to be changed in the future studies than M/H CoE. However, the effect size was not different (p = 1) when CoE changed from VL/L → M/H [ROR = 1.02 (95% CI: 0.74-1.39)] compared with M/H → VL/L (ROR = 1.02 [95% CI: 0.44-2.37]). Similar overlap in aROR between the VL/L → M/H versus M/H → VL/L subgroups was observed [median (IQR): 1.12 (1.07-1.57) vs. 1.21 (1.12-2.43)]. We observed large inconsistency across ROR estimates (I

conclusionsWe found that low-quality evidence changes more often than high CoE. However, the effect size did not systematically differ between the studies with low versus high CoE. The finding that the effect size did not differ between low and high CoE indicate urgent need to refine current EBM critical appraisal methods.

Indexed as

Systematic Reviews as TopicHumanscritical appraisal-biasevidence-based medicinemeta-epidemiologyobservational studiesrandom errorrandomized trialssystematic review

Identifiers

PMID35089627
PMCPMC9305903

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.